Rick Fair, president and chief executive officer, Bellicum Pharmaceuticals, discussed the company’s programs and future plans.
Rick Fair
Advertisement
President and chief executive officer, Bellicum Pharmaceuticals
Articles by Rick Fair
Rick Fair, president and chief executive officer, Bellicum Pharmaceuticals, discussed the company’s GoCAR, iMC, and caspaCIDe technologies.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CGTlive®
1
Patients Treated With Spur Therapeutics’ Gaucher Disease Gene Therapy FLT201 Maintain Clinical Benefit for Up to 2 Years
2
Patients Treated With AskBio’s Limb-Girdle Muscular Dystrophy Gene Therapy AB-1003 Free of Serious Adverse Events at Up to 52 Weeks
3
CGTLive®’s Weekly Rewind – October 17, 2025
4
